Fluticasone propionate hydrofluoroalkane inhalation - GSK
Alternative Names: FLOVENT HFA; Fluticasone propionate HFA; Fluticasone propionate HFA inhalation - GSKLatest Information Update: 21 Apr 2025
At a glance
- Originator GlaxoSmithKline
- Developer GSK
- Class Analgesics; Androstadienes; Anti-inflammatories; Antiallergics; Antiasthmatics; Eye disorder therapies; Fluorinated steroids; Glucocorticoids; Inorganic sulfur compounds; Small molecules
- Mechanism of Action Glucocorticoid receptor agonists
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity No
Highest Development Phases
- Market Withdrawal Asthma